IONS
NASDAQ · Biotechnology
Ionis Pharmaceuticals Inc
$69.68
-1.11 (-1.57%)
Performance
1D
—
1W
—
1M
—
3M
-12.82%
6M
+8.72%
1Y
+115.93%
YTD
-12.54%
Open$70.27
Previous Close$70.79
Day High$70.64
Day Low$68.90
52W High$86.74
52W Low$23.95
Volume—
Avg Volume2.39M
Market Cap11.73B
P/E Ratio—
EPS$-2.47
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$80.92
Below
SMA 200
$60.03
Above
RSI (14)
47.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
29 analysts
Price Target
+7.5% upside
Current
$69.68
$69.68
Target
$74.94
$74.94
$58.43
$74.94 avg
$113.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 974.27M | 831.86M | 6.52B |
| Net Income | -393,735,162 | -302,562,880 | -1,853,302,223 |
| Profit Margin | -40.4% | -38.4% | -28.4% |
| EBITDA | -475,224,382 | -385,470,596 | -2,518,216,651 |
| Free Cash Flow | — | — | -1,126,512,375 |
| Rev Growth | +17.1% | +17.1% | -9.9% |
| Debt/Equity | 4.77 | 4.77 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |